NTLA
Price
$15.12
Change
-$0.99 (-6.15%)
Updated
Nov 14 closing price
97 days until earnings call
PSTX
Price
$3.21
Change
-$0.07 (-2.13%)
Updated
Nov 14 closing price
111 days until earnings call
Ad is loading...

NTLA vs PSTX

Header iconNTLA vs PSTX Comparison
Open Charts NTLA vs PSTXBanner chart's image
Intellia Therapeutics
Price$15.12
Change-$0.99 (-6.15%)
Volume$2.13M
CapitalizationN/A
Poseida Therapeutics
Price$3.21
Change-$0.07 (-2.13%)
Volume$535.76K
CapitalizationN/A
NTLA vs PSTX Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NTLA vs. PSTX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and PSTX is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (NTLA: $15.12 vs. PSTX: $3.21)
Brand notoriety: NTLA and PSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 94% vs. PSTX: 100%
Market capitalization -- NTLA: $1.54B vs. PSTX: $312.86M
NTLA [@Biotechnology] is valued at $1.54B. PSTX’s [@Biotechnology] market capitalization is $312.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whilePSTX’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • PSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, PSTX is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 5 TA indicator(s) are bullish while PSTX’s TA Score has 5 bullish TA indicator(s).

  • NTLA’s TA Score: 5 bullish, 4 bearish.
  • PSTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than PSTX.

Price Growth

NTLA (@Biotechnology) experienced а -5.50% price change this week, while PSTX (@Biotechnology) price change was +9.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 20, 2025.

PSTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.54B) has a higher market cap than PSTX($313M). PSTX YTD gains are higher at: -4.464 vs. NTLA (-50.410).
NTLAPSTXNTLA / PSTX
Capitalization1.54B313M492%
EBITDAN/AN/A-
Gain YTD-50.410-4.4641,129%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAPSTX
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with EDIT. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-6.15%
EDIT - NTLA
74%
Closely correlated
-6.42%
BEAM - NTLA
67%
Closely correlated
-4.33%
CRSP - NTLA
63%
Loosely correlated
-5.90%
PRME - NTLA
58%
Loosely correlated
-9.22%
DNLI - NTLA
56%
Loosely correlated
-3.98%
More

PSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTX
1D Price
Change %
PSTX100%
-2.13%
NTLA - PSTX
49%
Loosely correlated
-6.15%
ALEC - PSTX
47%
Loosely correlated
-4.20%
EDIT - PSTX
46%
Loosely correlated
-6.42%
INZY - PSTX
42%
Loosely correlated
-3.38%
CRSP - PSTX
41%
Loosely correlated
-5.90%
More